275 related articles for article (PubMed ID: 25990063)
1. Is impaired response inhibition independent of symptom dimensions in obsessive-compulsive disorder? Evidence from ERPs.
Lei H; Zhu X; Fan J; Dong J; Zhou C; Zhang X; Zhong M
Sci Rep; 2015 May; 5():10413. PubMed ID: 25990063
[TBL] [Abstract][Full Text] [Related]
2. Overactive performance monitoring in obsessive-compulsive disorder is independent of symptom expression.
Riesel A; Kathmann N; Endrass T
Eur Arch Psychiatry Clin Neurosci; 2014 Dec; 264(8):707-17. PubMed ID: 24676800
[TBL] [Abstract][Full Text] [Related]
3. Differential neural network of checking versus washing symptoms in obsessive-compulsive disorder.
Murayama K; Nakao T; Sanematsu H; Okada K; Yoshiura T; Tomita M; Masuda Y; Isomura K; Nakagawa A; Kanba S
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():160-6. PubMed ID: 22996045
[TBL] [Abstract][Full Text] [Related]
4. Withdrawn/Depressed Behaviors and Error-Related Brain Activity in Youth With Obsessive-Compulsive Disorder.
Hanna GL; Liu Y; Isaacs YE; Ayoub AM; Torres JJ; O'Hara NB; Gehring WJ
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):906-913.e2. PubMed ID: 27663946
[TBL] [Abstract][Full Text] [Related]
5. Inhibition-related differences between tic-free and tic-related obsessive-compulsive disorder: evidence from the N2 and P3.
Kloft L; Riesel A; Kathmann N
Exp Brain Res; 2019 Dec; 237(12):3449-3459. PubMed ID: 31734785
[TBL] [Abstract][Full Text] [Related]
6. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems.
van den Heuvel OA; Remijnse PL; Mataix-Cols D; Vrenken H; Groenewegen HJ; Uylings HB; van Balkom AJ; Veltman DJ
Brain; 2009 Apr; 132(Pt 4):853-68. PubMed ID: 18952675
[TBL] [Abstract][Full Text] [Related]
7. Overactive performance monitoring in obsessive-compulsive disorder: ERP evidence from correct and erroneous reactions.
Endrass T; Klawohn J; Schuster F; Kathmann N
Neuropsychologia; 2008; 46(7):1877-87. PubMed ID: 18514679
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of health-related quality of life in obsessive-compulsive disorder.
Albert U; Maina G; Bogetto F; Chiarle A; Mataix-Cols D
Compr Psychiatry; 2010; 51(2):193-200. PubMed ID: 20152302
[TBL] [Abstract][Full Text] [Related]
9. Perceived parental rearing style in obsessive-compulsive disorder: relation to symptom dimensions.
Alonso P; Menchón JM; Mataix-Cols D; Pifarré J; Urretavizcaya M; Crespo JM; Jiménez S; Vallejo G; Vallejo J
Psychiatry Res; 2004 Jul; 127(3):267-78. PubMed ID: 15296826
[TBL] [Abstract][Full Text] [Related]
10. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder.
Mataix-Cols D; Wooderson S; Lawrence N; Brammer MJ; Speckens A; Phillips ML
Arch Gen Psychiatry; 2004 Jun; 61(6):564-76. PubMed ID: 15184236
[TBL] [Abstract][Full Text] [Related]
11. Overactive Performance Monitoring as an Endophenotype for Obsessive-Compulsive Disorder: Evidence From a Treatment Study.
Riesel A; Endrass T; Auerbach LA; Kathmann N
Am J Psychiatry; 2015 Jul; 172(7):665-73. PubMed ID: 25783756
[TBL] [Abstract][Full Text] [Related]
12. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological correlates of behavioral response inhibition in patients with obsessive-compulsive disorder.
Kim MS; Kim YY; Yoo SY; Kwon JS
Depress Anxiety; 2007; 24(1):22-31. PubMed ID: 16933318
[TBL] [Abstract][Full Text] [Related]
14. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit.
Milad MR; Furtak SC; Greenberg JL; Keshaviah A; Im JJ; Falkenstein MJ; Jenike M; Rauch SL; Wilhelm S
JAMA Psychiatry; 2013 Jun; 70(6):608-18; quiz 554. PubMed ID: 23740049
[TBL] [Abstract][Full Text] [Related]
15. Latent class analysis of obsessive-compulsive symptoms in a clinical sample.
Atli A; Boysan M; Çetinkaya N; Bulut M; Bez Y
Compr Psychiatry; 2014 Apr; 55(3):604-12. PubMed ID: 24262128
[TBL] [Abstract][Full Text] [Related]
16. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test].
Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M
Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal event-related potential study of selective serotonin reuptake inhibitor therapy in treatment-naïve pediatric obsessive compulsive disorder patients.
Yamamuro K; Ota T; Iida J; Kishimoto N; Nakanishi Y; Matsuura H; Uratani M; Okazaki K; Kishimoto T
Psychiatry Res; 2016 Nov; 245():217-223. PubMed ID: 27552672
[TBL] [Abstract][Full Text] [Related]
18. Modulation of error monitoring in obsessive-compulsive disorder by individually tailored symptom provocation.
Roh D; Chang JG; Yoo SW; Shin J; Kim CH
Psychol Med; 2017 Sep; 47(12):2071-2080. PubMed ID: 28374659
[TBL] [Abstract][Full Text] [Related]
19. Family accommodation in obsessive-compulsive disorder: Relation to symptom dimensions, clinical and family characteristics.
Albert U; Bogetto F; Maina G; Saracco P; Brunatto C; Mataix-Cols D
Psychiatry Res; 2010 Sep; 179(2):204-11. PubMed ID: 20483467
[TBL] [Abstract][Full Text] [Related]
20. Components of inhibition in autogenous- and reactive-type obsessive-compulsive disorder: Dissociation of interference control.
Fan J; Liu W; Lei H; Cai L; Zhong M; Dong J; Zhou C; Zhu X
Biol Psychol; 2016 May; 117():117-130. PubMed ID: 26995786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
